A phase 3 multicenter study to evaluate the accuracy and clinical usefulness of the high-sensitivity next-generation sequencing panel using cytological specimens for lung cancer (cPANEL)

Supporters

Support the authors with ResearchCoin

Tip RSC

Topics

Computer Science

Cancer Oncology

Engineering

Medicine

Internal Medicine

Show all topics

DOI

10.1183/13993003.congress-2024.oa1090